Your browser doesn't support javascript.
loading
Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019-20 Influenza Season-A Retrospective Cohort Analysis.
Levin, Myron J; Divino, Victoria; Shah, Drishti; DeKoven, Mitch; Mould-Quevedo, Joaquin; Pelton, Stephen I; Postma, Maarten J.
Afiliación
  • Levin MJ; Departments of Pediatrics and Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO 80045, USA.
  • Divino V; Real World Solutions, IQVIA, Falls Church, VA 22042, USA.
  • Shah D; Real World Solutions, IQVIA, Falls Church, VA 22042, USA.
  • DeKoven M; Real World Solutions, IQVIA, Falls Church, VA 22042, USA.
  • Mould-Quevedo J; Global Pricing & Health Economics, Seqirus USA Inc., Summit, NJ 07901, USA.
  • Pelton SI; Department of Pediatrics, Boston University Schools of Medicine, Boston, MA 02118, USA.
  • Postma MJ; Division of Pediatric Infectious Diseases, Maxwell Finland Laboratory, Boston Medical Center, Boston, MA 02118, USA.
Vaccines (Basel) ; 9(10)2021 Oct 08.
Article en En | MEDLINE | ID: mdl-34696254

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza